“How many people have Huntington’s disease is a question that patients, families, and researchers ask every day. The condition is rare, but it carries life-changing consequences for everyone it touches. In 2025, estimates suggest that about 41,000 people in the United States live with Huntington’s disease, while more than 200,000 carry the genetic mutation that could eventually lead to symptoms.”
Legal United States (How Many People Have Huntington’s Disease? Full 2025 Breakdown)
A preliminary diagnosis of Huntington’s disease is based primarily on your answers to questions, a general physical exam, a review of your family medical history, and neurological and psychiatric examinations.
The neurologist will ask you questions and conduct relatively simple tests of your:
The neurologist may also perform standardized tests to check your:
You’ll likely be referred to a psychiatrist for an examination to look for a number of factors that could contribute to your diagnosis, including:
Your doctor may order brain-imaging tests for assessing the structure or function of the brain. The imaging technologies may include MRI or CT scans that show detailed images of the brain.
These images may reveal changes in the brain in areas affected by Huntington’s disease. These changes may not show up early in the course of the disease. These tests can also be used to rule out other conditions that may be causing symptoms.
If symptoms strongly suggest Huntington’s disease, your doctor may recommend a genetic test for the defective gene.
This test can confirm the diagnosis. It may also be valuable if there’s no known family history of Huntington’s disease or if no other family member’s diagnosis was confirmed with a genetic test. But the test won’t provide information that might help determinine a treatment plan.
Before having such a test, the genetic counselor will explain the benefits and drawbacks of learning test results. The genetic counselor can also answer questions about the inheritance patterns of Huntington’s disease.
A genetic test can be given if you have a family history of the disease but don’t have symptoms. This is called predictive testing. The test can’t tell you when the disease will begin or what symptoms will appear first.
Some people may have the test because they find not knowing to be more stressful. Others may want to take the test before having children.
Huntington’s disease is caused by an inherited defect in a single gene. Huntington’s disease is an autosomal dominant disorder, which means that a person needs only one copy of the defective gene to develop the disorder.
With the exception of genes on the sex chromosomes, a person inherits two copies of every gene — one copy from each parent. A parent with a defective gene could pass along the defective copy of the gene or the healthy copy. Each child in the family, therefore, has a 50 percent chance of inheriting the gene that causes the genetic disorder.
After the start of Huntington’s disease, a person’s functional abilities gradually worsen over time. The rate of disease progression and duration varies. The time from disease emergence to death is often about 10 to 30 years. Juvenile Huntington’s disease usually results in death within 10 years after symptoms develop.
The clinical depression associated with Huntington’s disease may increase the risk of suicide. Some research suggests that the greater risk of suicide occurs before a diagnosis is made and in the middle stages of the disease when a person has begun to lose independence.
Eventually, a person with Huntington’s disease requires help with all activities of daily living and care. Late in the disease, he or she will likely be confined to a bed and unable to speak. However, he or she is generally able to understand language and has an awareness of family and friends.
Common causes of death include:
People with a known family history of Huntington’s disease are understandably concerned about whether they may pass the Huntington gene on to their children. These people may consider genetic testing and family planning options.
If an at-risk parent is considering genetic testing, it can be helpful to meet with a genetic counselor. A genetic counselor will discuss the potential risks of a positive test result, which would indicate the parent will develop the disease. Also, couples will need to make additional choices about whether to have children or to consider alternatives, such as prenatal testing for the gene or in vitro fertilization with donor sperm or eggs.
Another option for couples is in vitro fertilization and preimplantation genetic diagnosis. In this process, eggs are removed from the ovaries and fertilized with the father’s sperm in a laboratory. The embryos are tested for presence of the Huntington gene, and only those testing negative for the Huntington gene are implanted in the mother’s uterus.
“Huntington’s disease causes nerve cells in the brain to decay over time. The disease affects a person’s movements, thinking ability and mental health. Huntington’s disease is rare. It’s often passed down through a changed gene from a parent. Huntington’s disease symptoms can develop at any time, but they often begin when people are in their 30s or 40s. If the disease develops before age 20, it’s called juvenile Huntington’s disease.”
MAYO CLINIC
Huntington’s disease is an inherited disease that causes the progressive breakdown (degeneration) of nerve cells in the brain. Huntington’s disease has a broad impact on a person’s functional abilities and usually results in movement, thinking (cognitive) and psychiatric disorders.
Most people with Huntington’s disease develop signs and symptoms in their 30s or 40s. But the disease may emerge earlier or later in life.
When the disease develops before age 20, the condition is called juvenile Huntington’s disease. An earlier emergence of the disease often results in a somewhat different set of symptoms and faster disease progression.
Medications are available to help manage the symptoms of Huntington’s disease, but treatments can’t prevent the physical, mental and behavioral decline associated with the condition.
Huntington’s disease usually causes movement, cognitive and psychiatric disorders with a wide spectrum of signs and symptoms. Which symptoms appear first varies greatly among affected people. During the course of the disease, some disorders appear to be more dominant or have a greater effect on functional ability.
The movement disorders associated with Huntington’s disease can include both involuntary movement problems and impairments in voluntary movements, such as:
Impairments in voluntary movements — rather than the involuntary movements — may have a greater impact on a person’s ability to work, perform daily activities, communicate and remain independent.
Cognitive impairments often associated with Huntington’s disease include:
The most common psychiatric disorder associated with Huntington’s disease is depression. This isn’t simply a reaction to receiving a diagnosis of Huntington’s disease. Instead, depression appears to occur because of injury to the brain and subsequent changes in brain function. Signs and symptoms may include:
Other common psychiatric disorders include:
In addition to the above symptoms, weight loss is common in people with Huntington’s disease, especially as the disease progresses.
The start and progression of Huntington’s disease in younger people may be slightly different from that in adults. Problems that often present themselves early in the course of the disease include:
“Buerger disease is a rare disease of the arteries and veins in the arms and legs. In Buerger disease — also called thromboangiitis obliterans — blood vessels become blocked.
There’s no cure for Buerger disease. The only proven treatment for Buerger disease is to quit using all tobacco products. Even one cigarette a day can make the disease worse. This includes using electronic cigarettes, vaping and using marijuana.”
MAYO CLINIC (Buerger disease – Diagnosis and treatment – Mayo Clinic)
This disease was first reported by Buerger in 1908, who described a disease in which the characteristic pathologic findings — acute inflammation and thrombosis (clotting) of arteries and veins — affected the hands and feet. Another name for Buerger’s Disease is thromboangiitis obliterans.
The classic Buerger’s Disease patient is a young male (e.g., 20–40 years old) who is a heavy cigarette smoker. More recently, however, a higher percentage of women and people over the age of 50 have been recognized to have this disease. Buerger’s disease is most common in the Orient, Southeast Asia, India and the Middle East, but appears to be rare among African–Americans.
Despite the severity of ischemia (lack of blood flow) to the distal extremities that occurs in Buerger’s, the disease does not involve other organs, unlike many other forms of vasculitis. Even as ulcers and gangrene develop in the digits, organs such as the lung, kidneys, brain, and gastrointestinal (GI) tract remain unaffected. The reasons for the confinement to the extremities and sparing of other organs are not known.
The association of Buerger’s Disease is with tobacco use, particularly cigarette smoking, cannot be overemphasized. Most patients with Buerger’s are heavy smokers, but some cases occur in patients who smoke “moderately”; others have been reported in users of smokeless tobacco. It has been postulated that Buerger’s Disease is an “autoimmune” reaction (one in which the body’s immune system attacks the body’s own tissues) triggered by some constituent of tobacco.
The patient’s fingertips develope gangrene. This is a very painful condition which sometimes requires amputation of the affected area.
Buerger’s disease can be mimicked by a wide variety of other diseases that cause diminished blood flow to the extremities. These other disorders must be ruled out with an aggressive evaluation, because their treatments differ substantially from that of Buerger’s Disease (for Buerger’s, there is only one treatment known to be effective: complete smoking cessation — see below).
Diseases with which Buerger’s Disease may be confused include atherosclerosis (build–up of cholesterol plaques in the arteries), endocarditis (an infection of the lining of the heart), other types of vasculitis, severe Raynaud’s phenomenon associated with connective tissue disorders (e.g., lupus or scleroderma), clotting disorders of the blood, and others.
It should be noted that other substances, such as marijuana, have also been associated with a vasculitis similar to Buerger’s or polyarteritis nodosa that should be considered in the differential diagnosis.
Angiograms of the upper and lower extremities can be done.
Buerger’s disease can be mimicked by a wide variety of other diseases that cause diminished blood flow to the extremities. These other disorders must be ruled out with an aggressive evaluation, because their treatments differ substantially from that of Buerger’s Disease (for Buerger’s, there is only one treatment known to be effective: complete smoking cessation — see below).
Diseases with which Buerger’s Disease may be confused include atherosclerosis (build–up of cholesterol plaques in the arteries), endocarditis (an infection of the lining of the heart), other types of vasculitis, severe Raynaud’s phenomenon associated with connective tissue disorders (e.g., lupus or scleroderma), clotting disorders of the blood, and others.
It should be noted that other substances, such as marijuana, have also been associated with a vasculitis similar to Buerger’s or polyarteritis nodosa that should be considered in the differential diagnosis.
Angiograms of the upper and lower extremities can be helpful in making the diagnosis of Buerger’s disease. In the proper clinical setting, certain angiographic findings are diagnostic of Buerger’s. These findings include a “corkscrew” appearance of arteries that result from vascular damage, particularly the arteries in the region of the wrists and ankles. Angiograms may also show occlusions (blockages) or stenoses (narrowings) in multiple areas of both the arms and legs.
Pictured below on the left is a normal angiogram. On the right, is an abnormal angiogram of an arm demonstrating the classic “corkscrew” appearance of arteries to the hand. The changes are particularly apparent in the blood vessels in the lower right hand portion of the picture (the ulnar artery distribution).
NORMAL ANGIOGRAM VS ABNORMAL ANGIOGRAM
Another Abnormal Angiogram in hand for Buerger’s Disease
View in abnormal angio’s lacking of the dark black in fingers and thumbs as opposed to the normal one above.
In order to rule out other forms of vasculitis (by excluding involvement of vascular regions atypical for Buerger’s), it is sometimes necessary to perform angiograms of other body regions (e.g., a mesenteric angiogram).
Skin biopsies of affected extremities are rarely performed because of the frequent concern that a biopsy site near an area poorly perfused with blood will not heal well.
It is essential that patients with Buerger’s disease stop smoking immediately and completely. This is the only treatment known to be effective in Buerger’s disease. Patients who continue to smoke are generally the ones who require amputation of fingers and toes.
Despite the clear presence of inflammation in this disorder, anti-inflammatory agents such as steroids have not been shown to be beneficial. Similarly, strategies of anticoagulation (thinning of the blood with aspirin or other agents to prevent clots) have not proven effective. The only way to prevent the progression of the disease is to abstain from all tobacco products.
“Akinetic keratosis is a rare, noncancerous skin condition characterized by persistent, scaly patches that do not regress spontaneously. It is often associated with chronic sun damage and may resemble actinic keratosis (AK) or keratoacanthoma (KA) in appearance, but it is distinct in its lack of spontaneous regression.”
The Skin Cancer Foundation (ps://www.skincancer.org/skin-cancer-information/actinic-keratosis/actinic-keratosis-warning-signs-and-images/)
Keratoacanthoma is a fast-growing, dome-shaped skin bump that can mimic squamous cell carcinoma and is usually treated as if it were cancer.
Cleveland Clinic (Keratoacanthoma: Symptoms, Causes & Treatment)
Actinic keratosis (AK) is a skin disorder that causes rough, scaly patches of skin. Another name for AK is solar keratosis. AK is a type of precancer, which means that if you don’t treat the condition, it could turn into cancer. Without treatment, AK can lead to a type of skin cancer called squamous cell carcinoma.
–UV exposure from the sun or indoor tanning.
-History of skin cancer in particular history of actinic keratosis.
-Fair skin: People with fair skin including lighter color hair or eyes have an increased risk.
Warning Signs can help with early detection and treatment this can be successfully removed without complications. Look out for any new, changing or unusual skin growths, so you can spot skin cancers like BCC when they are easiest to treat and cure.
An actinic keratosis sometimes disappears on its own but might return after more sun exposure. It’s hard to tell which actinic keratoses will develop into skin cancer, so they’re usually removed as a precaution.
If you have several actinic keratoses, your health care provider might prescribe a medicated cream or gel to remove them, such as fluorouracil (Carac, Efudex others), imiquimod (Aldara, Zyclara) or diclofenac. These products might cause inflamed skin, scaling or a burning sensation for a few weeks.
Many methods are used to remove actinic keratosis, including:
The term “Keratoacanthoma” (KA) was coined by Freudenthal in the year 1936. It was first described way back in 1889 by Hutchinson and was called molluscum sebaceum and self-limiting epithelioma. KA is benign, self-limiting squamo-proliferative lesion.
It shows male preponderance and most commonly arises on the sun-exposed parts predominantly face, neck forearms, hands and legs. Cutaneous lesions arise from hair follicles whereas mucosal lesions originate from ectopic sebaceous glands. This is a slow growing cancer of the skin that looks like a dome or crater. This is common; more than 200,000 cases per year in US. Regarding treatment from medical professional is advised. This condition often requires lab test or imaging. Keratoacanthoma last several months. It is common for ages 60 and older and is more common in males.
–UV exposure from the sun or indoor tanning.
-contact with chemical carcinogens, or cancer-causing chemicals
-Infection with some strains of a wart virus, such as papillomavirus
-History of skin cancer in particular history of Keratoacanthoma.
Warning Signs can help with early detection and treatment, this can be successfully removed without complications if caught early. Look out for any new, changing or unusual skin growths, so you can spot skin cancers like BCC when they are easiest to treat and cure.
If your medical professional suspects a keratoacanthoma, they will first want to establish the correct diagnosis by performing a biopsy. Than treatments could include the following:
Very rarely, keratoacanthomas are treated with medicine injected directly into the skin lesion (intralesional chemotherapy). In patients with more than one keratoacanthoma, the medical professional may suggest taking oral medication (ie, isotretinoin) to reduce their size and number.
Once the skin cancer has been removed, frequent follow-up appointments with a dermatologist or medical professional trained to examine the skin are essential to ensure that the keratoacanthoma has not returned and that no new skin cancer has developed elsewhere on your body. In addition, good sun protection habits (as noted in the Self-Care section) are vital to preventing further damage from UV light.